Schonfeld Strategic Advisors’s Relmada Therapeutics RLMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-109,310
Closed -$328K 2012
2023
Q3
$328K Buy
+109,310
New +$328K ﹤0.01% 1184
2023
Q1
Sell
-75,300
Closed -$263K 2454
2022
Q4
$263K Sell
75,300
-75,200
-50% -$262K ﹤0.01% 1832
2022
Q3
$5.57M Buy
+150,500
New +$5.57M 0.05% 492
2022
Q1
Sell
-54,800
Closed -$1.24M 2662
2021
Q4
$1.24M Sell
54,800
-58,138
-51% -$1.31M 0.01% 777
2021
Q3
$2.96M Buy
112,938
+55,177
+96% +$1.45M 0.03% 529
2021
Q2
$1.85M Buy
57,761
+3,260
+6% +$104K 0.02% 706
2021
Q1
$1.92M Buy
+54,501
New +$1.92M 0.02% 644